The New England Signal
Independent journalism covering all six New England states
Connecticut

Texas man convicted of selling misbranded prescription drugs through websites and Facebook group

A federal jury in New Haven found Ryan Fields, 52, guilty of conspiracy charges after prosecutors said he and a former Glastonbury woman sold unapproved drugs online without prescriptions, collecting more than $1.4 million.

A federal jury in New Haven convicted a Texas man of illegally selling misbranded and unapproved prescription drugs through two websites and a private Facebook group, the U.S. attorney's office for Connecticut said Monday.

Ryan Fields, 52, of Port Neches, Texas, was found guilty Sept. 18 of conspiring to introduce misbranded or unapproved drugs into interstate commerce and to smuggle goods into the United States, and of conspiring to commit money laundering, prosecutors said.

According to evidence at trial, Fields and Lisa Mahan, who used to live in Glastonbury, ran the websites pinnedaminos.com and projectaminos.com and a private Facebook group called Pinned Aminos from September 2021 to June 2023, selling drugs to customers across the country without requiring a prescription. Some of the drugs had not been approved by the Food and Drug Administration for human use, and some were imported illegally from foreign manufacturers, prosecutors said.

The websites and product labels described the drugs as research compounds not intended for human consumption, but Fields and Mahan told customers about health benefits and dosages in emails and Facebook posts, prosecutors said.

Fields shipped more than 10,000 packages and collected more than $1.4 million, according to prosecutors, who said the money went toward cars and a Texas house. The jury ordered the house and a car forfeited.

Fields is free on bond and has not been given a sentencing date. Mahan, 56, pleaded guilty to the conspiracy charge April 6 and was sentenced Aug. 13 to three years of probation.

This brief was drafted by AI from a public agency press release and published by The New England Signal. Why we use AI for stories like this one.

Connecticut